Maria Wolodarski

PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates

R. Kiessling, J. Hansson, T. Nakajima, 2020, Oncoimmunology.

IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients

G. Madonna, D. Mallardo, P. Ascierto, 2017, Oncoimmunology.

Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination

R. Kiessling, R. Tell, J. Hansson, 2020, Oncoimmunology.

Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma

R. Kiessling, Yuan Yang, J. Hansson, 2017, Oncotarget.

High expression of ID1 in monocytes is strongly associated with phenotypic and functional MDSC markers in advanced melanoma

R. Kiessling, J. Hansson, J. Melief, 2020, Cancer Immunology, Immunotherapy.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, A. Hauschild, J. Malvehy, 2016, Journal of Translational Medicine.

Predicting anti-PD-1 responders in malignant melanoma from the frequency of S100A9+ monocytes in the blood

J. Tegnér, D. Gómez-Cabrero, R. Kiessling, 2021, Journal for ImmunoTherapy of Cancer.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, Ludmila V. Danilova, David C. Smith, 2016, Journal of Translational Medicine.

A Non-Interventional Study on Vismodegib for Basal Cell Carcinoma in Swedish Patients

J. Paoli, K. Söderkvist, N. Bendsöe, 2023, Dermatology practical & conceptual.

Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS-Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study

D. Schadendorf, C. Dooms, P. Ascierto, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.